Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-06 4:55 pm Purchase |
2023-10-26 | 13G | Stoke Therapeutics, Inc. STOK |
Lynx1 Capital Management LP | 2,664,158 6.000% |
2,664,158 (New Position) |
Filing History |
| 2023-02-14 10:08 am Purchase |
2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,870,981 9.800% |
226,733 (+6.22%) |
Filing History |
| 2023-02-10 11:50 am Purchase |
2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK |
MORGAN STANLEY MS |
2,448,214 6.200% |
2,448,214 (New Position) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Stoke Therapeutics, Inc. STOK |
FMR CORP | 3,034,649 7.696% |
479,850 (+18.78%) |
Filing History |
| 2023-02-09 11:32 am Sale |
2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK |
The Vanguard Group | 1,602,045 4.060% |
-310,137 (-16.22%) |
Filing History |
| 2023-02-03 5:16 pm Purchase |
2022-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 4,166,975 9.700% |
1,920,307 (+85.47%) |
Filing History |
| 2023-01-25 3:45 pm Sale |
2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 1,248,077 1.890% |
-623,452 (-33.31%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,246,668 6.100% |
-439,566 (-16.36%) |
Filing History |
| 2022-02-14 08:07 am Purchase |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,644,248 9.900% |
100,000 (+2.82%) |
Filing History |
| 2022-02-10 08:37 am Purchase |
2021-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
The Vanguard Group | 1,912,182 5.200% |
1,912,182 (New Position) |
Filing History |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Stoke Therapeutics, Inc. STOK |
FMR CORP | 2,554,799 6.944% |
-1,046,176 (-29.05%) |
Filing History |
| 2022-01-24 07:44 am Purchase |
2022-01-19 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 1,871,529 5.090% |
1,871,529 (New Position) |
Filing History |
| 2021-06-30 4:19 pm Purchase |
2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK |
Skorpios Trust | 14,443,681 39.300% |
14,443,681 (New Position) |
Filing History |
| 2021-06-28 8:54 pm Sale |
2021-06-21 | 13D | Stoke Therapeutics, Inc. STOK |
ATP Life Science Ventures L.P. | 1,912,256 5.200% |
-15,293,789 (-88.89%) |
Filing History |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
Redmile Group LLC | 2,686,234 7.400% |
2,686,234 (New Position) |
Filing History |
| 2021-02-16 3:15 pm Sale |
2021-02-16 | 13G | Stoke Therapeutics, Inc. STOK |
Cormorant Asset Management LP | 1,437,807 3.970% |
-350,856 (-19.62%) |
Filing History |
| 2021-02-16 10:07 am Sale |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
GILDER GAGNON HOWE & CO LLC | 1,470,841 4.060% |
-356,360 (-19.50%) |
Filing History |
| 2021-02-12 09:40 am Unchanged |
2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK |
RTW Investments, LP | 3,544,248 9.890% |
0 (Unchanged) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Stoke Therapeutics, Inc. STOK |
FMR CORP | 3,600,975 9.937% |
3,600,975 (New Position) |
Filing History |
| 2020-11-27 4:58 pm Purchase |
2020-11-20 | 13D | Stoke Therapeutics, Inc. STOK |
ATP Life Science Ventures L.P. | 17,206,045 47.500% |
419,332 (+2.50%) |
Filing History |